(Q41428801)

30 September 2017

1 reference

title

Short-course chemoprophylaxis for tuberculosis (English)

1 reference

30 September 2017

Bishai WR

1

1 reference

30 September 2017

Chaisson RE

series ordinal

2

1 reference

30 September 2017

publication date

1 March 1997

1 reference

Clinics in Chest Medicine

30 September 2017

published in

1 reference

30 September 2017

volume

18

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

115-122

1 reference

Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic Methods

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

The clinical pharmacokinetics of rifabutin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

In vitro properties of rifapentine (MDL473) relevant to its use in intermittent chemotherapy of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin. Rifabutin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Less is more: short-course preventive therapy of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Effectiveness of rifabutin alone or in combination with isoniazid in preventive therapy of mouse tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Comparison of activities of rifapentine and rifampin against Mycobacterium tuberculosis residing in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Isoniazid-associated hepatitis deaths: a review of available information

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Much's granules revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Synchronized replication of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Dormancy of Mycobacterium tuberculosis and latency of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Rifampicin-resistant Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970360-9

7 January 2021

10.1016/S0272-5231(05)70360-9

Identifiers

DOI

1 reference

30 September 2017

1 reference